GRM5 and oral cavity squamous cell carcinoma: mGlu5 in oral squamous cell carcinoma [91], the NMDA receptor type 2B in gastric cancer [92] and the N-methyl-D-aspartate receptor (NMDAr) in prostate cancer [93].